Mehtap TUGRAK, Halise Inci GUL, Baris ANİL, Ilhami GULCİN

Synthesis and pharmacological effects of novel benzenesulfonamides carrying benzamide moiety as carbonic anhydrase and acetylcholinesterase inhibitors

N-(1-(4-Methoxyphenyl)-3-oxo-3((4-(N-(substituted)sulfamoyl)phenypamino)prop-1-en-1-yl)benzamides 3a - g were designed since sulfonamide and benzamide pharmacophores draw great attention in novel drug design due to their wide range of bioactivities including acetylcholinesterase (AChE) and human carbonic anhydrase I and II (hCA I and hCA II) inhibitory potencies. Structure elucidation of the compounds was carried out by H-1 NMR, C-13 NMR, and HRMS spectra. In vitro enzyme assays showed that the compounds had significant inhibitory potential against hCA I, hCA II, and AChE enzymes at nanomolar levels. Ki values were in the range of 4.07 +/- 0.38 - 29.70 +/- 3.18 nM for hCA I and 10.68 +/- 0.98 - 37.16 +/- 7.55 nM for hCA II while Ki values for AChE were in the range of 8.91 +/- 1.65 - 34.02 +/- 5.90 nM. The most potent inhibitors 3g (Ki = 4.07 +/- 0.38 nM, hCA I), 3c (Ki = 10.68 +/- 0.98 nM, hCA II), and 3f (Ki = 8.91 +/- 1.65 nM, AChE) can be considered as lead compounds of this study with their promising bioactivity results. Secondary sulfonamides showed promising enzyme inhibitory effects on AChE while primary sulfonamide derivative was generally effective on hCA I and hCA II isoenzymes.

Keywords:

Sulfonamide benzamide, carbonic anhydrase, acetylcholinesterase, enzyme inhibition,

PDF

___

Abdoli M, 2018, METABOLITES, V8, DOI 10.3390/metabo8020037
Akbaba Y, 2014, J ENZYM INHIB MED CH, V29, P35, DOI 10.3109/14756366.2012.750311
Aki-Sener E, 2002, FARMACO, V57, P451, DOI 10.1016/S0014-827X(02)01226-0
AKISENER E, 2000, FARMACO, V55, P469 .
Asif M., 2016, MOD CHEM APPL, V4, P1, DOI [10.4172/2329-6798.1000194, DOI 10.4172/2329-6798.1000194]
Basar E, 2016, J ENZYM INHIB MED CH, V31, P1356, DOI 10.3109/14756366.2015.1134524
Bondi MW, 2017, J INT NEUROPSYCH SOC, V23, P818, DOI 10.1017/S135561771700100X
Bozdag M, 2017, BIOORGAN MED CHEM, V25, P677, DOI 10.1016/j.bmc.2016.11.039
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
Chirra S., 2016, WORLD J PHARM PHARM, V5, P1015
Darvesh S, 2016, CURR ALZHEIMER RES, V13, P1173, DOI 10.2174/1567205013666160404120542
ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9
Georgey HH, 2019, BIOORG CHEM, V82, P109, DOI 10.1016/j.bioorg.2018.09.037
Gul HI, 2019, BIOORG CHEM, V90, DOI 10.1016/j.bioorg.2019.103057
Gul HI, 2016, J ENZYM INHIB MED CH, V31, P1619, DOI 10.3109/14756366.2016.1160077
Karlawish Jason, 2017, Alzheimers Dement, V13, P374, DOI 10.1016/j.jalz.2017.02.006
Kratky M, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9110698
Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036
Manasa KL, 2020, METABOLITES, V10, DOI 10.3390/metabo10040136
Pau A, 1999, FARMACO, V54, P524, DOI 10.1016/S0014-827X(99)00057-9
Realdon O, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-1132-y
Rodriguez-Lavado J, 2020, EUR J MED CHEM, V198, DOI 10.1016/j.ejmech.2020.112368
Saglik BN, 2020, EUR J MED CHEM, V198, DOI 10.1016/j.ejmech.2020.112392
Saleem M, 2016, MED CHEM RES, V25, P438, DOI 10.1007/s00044-015-1493-7
Sawatzky E, 2016, J MED CHEM, V59, P2067, DOI 10.1021/acs.jmedchem.5b01674
Sobolova K, 2020, EUR J MED CHEM, V203, DOI 10.1016/j.ejmech.2020.112593
Soliman AM, 2020, EUR J MED CHEM, V200, DOI 10.1016/j.ejmech.2020.112449
Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467
Supuran CT, 2018, METABOLITES, V8, DOI 10.3390/metabo8020025
Supuran CT, 2016, J ENZYM INHIB MED CH, V31, P1254, DOI 10.1080/14756366.2016.1201479
Supuran CT, 2016, BIOCHEM J, V473, P2023, DOI 10.1042/BCJ20160115
Supuran CT, 2010, BIOORG MED CHEM LETT, V20, P3467, DOI 10.1016/j.bmcl.2010.05.009
Tugrak M, 2020, J HETEROCYCLIC CHEM, V57, P2762, DOI 10.1002/jhet.3985
Tugrak M, 2019, BIOORG CHEM, V90, DOI 10.1016/j.bioorg.2019.103095
Tugrak M, 2018, BIOORG CHEM, V81, P433, DOI 10.1016/j.bioorg.2018.09.013
Ulus R, 2016, BIOORGAN MED CHEM, V24, P3548, DOI 10.1016/j.bmc.2016.05.064
Vanghelovici M, 1960, SER STIINT CHIM, V6, P103
VERPOORTE JA, 1967, J BIOL CHEM, V242, P4221
Wani TV, 2018, J ENZYM INHIB MED CH, V33, P962, DOI 10.1080/14756366.2018.1471475
Yamali C, 2020, BIOORG CHEM, V96, DOI 10.1016/j.bioorg.2020.103627
Yigit B, 2019, J MOL STRUCT, V1179, P709, DOI 10.1016/j.molstruc.2018.11.038